Treatment of multiple sclerosis with natalizumab: experiences from a real-life cohort over 15 years

被引：0
|
作者：
Auer, M. [1 ]
Zinganell, A. [1 ]
Hegen, H. [1 ]
Bsteh, G. [2 ]
Di Pauli, F. [1 ]
Berek, K. [1 ]
Fava, E. [1 ]
Wurth, S. [3 ]
Berger, T. [2 ]
Deisenhammer, F. [1 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] Med Univ Vienna, Vienna, Austria
[3] Med Univ Graz, Graz, Austria
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P693
引用
收藏
页码：588 / 588
页数：1
相关论文
共 50 条
  • [41] Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry
    Guger, M.
    Enzinger, C.
    Leutmezer, F.
    Kraus, J.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 198 - 198
  • [42] Dimethyl-fumarate and teriflunomide for multiple sclerosis in a real-life setting: a French retrospective cohort study
    Conde, S.
    Moisset, X.
    Pereira, B.
    Zuel, M.
    Colamarino, R.
    Maillet-Vioud, M.
    Lauxerois, M.
    Taithe, F.
    Clavelou, P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 688 - 689
  • [43] Efficacy/safety profile of cladribine in an italian real-life cohort of relapsing remitting multiple sclerosis patients
    Zanetta, C.
    Sangalli, F.
    Guerrieri, S.
    Filippi, M.
    Montini, F.
    Moiola, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 325 - 325
  • [44] Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotype
    Zanghi, Aurora
    Galgani, Simonetta
    Bellantonio, Paolo
    Zaffaroni, Mauro
    Borriello, Giovanna
    Inglese, Matilde
    Romano, Silvia
    Conte, Antonella
    Patti, Francesco
    Trojano, Maria
    Avolio, Carlo
    D'Amico, Emanuele
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (09) : 2736 - 2744
  • [45] (426) CLINICAL FOLLOW-UP OF PATIENTS WITH MULTIPLE SCLEROSIS 10 YEARS AFTER PDE5IS TREATMENT FOR ERECTILE DYSFUNCTION: A REAL-LIFE COHORT STUDY
    Thomas, Charalampos
    Kratiras, Zisis
    Samarinas, Michael
    Diamantis, Georgios
    Konstantinidis, Charalampos
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [46] Real-life data of ten years with omalizumab treatment
    Karayazi, Damla Gunduz
    Simsek, Gokcen Omeroglu
    Sevinc, Can
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [47] Real-life use of natalizumab: safety data from the Austrian Nation-wide Natalizumab Registry
    Vass, K.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S442 - S442
  • [48] Asthma control over 3 years in a real-life study
    Lundback, Bo
    Ronmark, Eva
    Lindberg, Anne
    Jonsson, Ann-Christin
    Larsson, Lars-Gunnar
    James, Mark
    RESPIRATORY MEDICINE, 2009, 103 (03) : 348 - 355
  • [49] Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience
    Sator, Paul
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (08) : 147 - 158
  • [50] Real-life mobility-response criteria in patients with multiple sclerosis starting fampidrine treatment
    Stellmann, J. -P.
    Neuhaus, A.
    Jlussi, M.
    Heesen, C.
    Daumer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 502 - 503
12345